Webcast CME

Series Activities

Series Menu

Pathology & Laboratory Medicine Grand Rounds 2021
Webcasts

Sarcoma Genomics: Does Advancing Science Also Advance Patient Care?

Print this Content

Release date: August 24, 2021
Expiration date: August 24, 2023

Estimated Time of Completion: 1 hour

Description

Pathology & Laboratory Medicine Grand Rounds 2021 CME-certified webcast series features presentations from the Pathology & Laboratory Medicine Institute Grand Rounds. Faculty provide evidence-based guidance on the diagnosis and management of challenging cases in prostate disease, renal neoplasms, GI, hepatobiliary/ pancreatic, endometrial and uterine masses, pancreatic and lung cytology, bone and soft tissue lesions and pulmonary pathology. 

Learning Objectives

  1. Recognize pathologic findings in disease states.
  2. Use diagnostic tests appropriately.
  3. Interpret results of diagnostic tests.
  4. Demonstrate current knowledge in support of clinical practice.

Target Audience

The online series is designed for pathologists and allied health practitioners and students interested in pathology and laboratory medicine.

Accreditation

In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Maintenance of Certification
Successful completion of this CME activity enables the participant to earn up to 1.0 Lifelong Learning (Part II) MOC credits in the American Board of Pathology’s Maintenance of Certification Program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting MOC credit.

Activity Directors, Planning Committee and Faculty

Activity Directors

Steven Billings, MD
Co-section Head, Dermatopathology Section
Department of Anatomic Pathology
Pathology & Laboratory Medicine Institute
Cleveland Clinic
Cleveland, OH

Deborah Chute, MD
Pathology & Laboratory Medicine Institute
Cleveland Clinic
Cleveland, OH

Gary W. Procop, MD, MS
Medical Director and Co-Chair
Enterprise Laboratory Stewardship Committee
Director of Molecular Microbiology, Virology, Mycology and Parasitology
Pathology & Laboratory Medicine Institute
Cleveland Clinic
Cleveland, OH

Pathology & Laboratory Medicine Institute Planning Committee

Caroline Astbury, PhD
Michael Cruise, MD
Amy S. Joehlin-Price, MD
Jennifer S. Ko, MD
Jesse Mckenney, MD
Adam McShane, PhD
Megan Nakashima, MD
Sarah Ondrejka, DO
Christopher Przybycin, MD
Jordan Reynolds, MD
Gloria Zhang, MD

Faculty

Alexander Lazer, MD, PhD
Director, Sarcoma and Melanoma Clinical Genomics Program
Director, Selective (Soft Tissue) Pathology Fellowship Training Program
Professor
Departments of Pathology, Genomic MEdicine, Dermatology, Translational Molecular Pathology
MD Anderson Cancer Center
Houston, TX

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias. 

The following faculty have indicated that he may have a relationship, which in the context of his presentation(s), could be perceived as a potential conflict of interest: Alexander Lazar, MD: Abbvie Pharmaceuticals - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). ArcherDx - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). Astra Zeneca - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). BMS - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). Bayer - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). Beta-Cat Pharmaceuticals - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). Elsevier - Board Membership, Consulting, Intellectual property rights (Royalties or patent sales), Membership on advisory committee or review panels , Ownership interest (stock, stock options). Flagship Pioneering - Board Membership, Consulting, Intellectual property rights (Royalties or patent sales), Membership on advisory committee or review panels , Ownership interest (stock, stock options). Foghorn Therapeutics - Board Membership, Consulting, Intellectual property rights (Royalties or patent sales), Membership on advisory committee or review panels , Ownership interest (stock, stock options). Foghorn Therapeutics, Flagship Pioneering, Human Longevity Inc, Nucleai, Elsevier, SpringerNature, USCAP, CAP, AACR, ASCO, WHO / IARC, various VC, strategic consultancies, & marketing concerns - Board Membership, Consulting, Intellectual property rights (Royalties or patent sales), Membership on advisory committee or review panels , Ownership interest (stock, stock options). GSK - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). GSK, Novartis, BMS, Pfizer, Loxo / Bayer, AbbVie, Astra-Zeneca / MedImmune, Merck, Roche / Genentech / Ignyta, ArcherDx, Illumina, ThermoFisher, Beta-Cat Pharmaceuticals / Iterion Therapeutics, - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). Genentech/Roche - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). Human Longevity, Inc. - Board Membership, Consulting, Intellectual property rights (Royalties or patent sales), Membership on advisory committee or review panels , Ownership interest (stock, stock options). Ignyta - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). Illumina, Inc. - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). Iterion Therapeutics - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). LOXO Pharmaceuticals - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). Medimmune - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). Merck - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). Novartis - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). Nucleai - Board Membership, Consulting, Intellectual property rights (Royalties or patent sales), Membership on advisory committee or review panels , Ownership interest (stock, stock options). Pfizer - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). SpringerNature - Board Membership, Consulting, Intellectual property rights (Royalties or patent sales), Membership on advisory committee or review panels , Ownership interest (stock, stock options). Thermo Fisher Scientific Inc., - Board Membership, Consulting, Membership on advisory committee or review panels , Ownership interest (stock, stock options). Deciphera Pharmaceuticals - Research / Independent Contractor, Membership on advisory committee or review panels .

The following faculty have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest: Steven Billings, MD, Deborah Chute, MD, Gary W Procop, MD, Caroline Astbury, PhD, Michael Cruise, MD, Amy S JoehlinPrice, MD, Jennifer S Ko, MD, Jesse Mckenney, MD, Adam McShane, PhD, Megan Nakashima, MD, Sarah Ondrejka, DO, Christopher Przybycin, MD, Jordan Reynolds, MD, Gloria Zhang, MD, Gloria Zhang, MD


This CME activity was produced by the Cleveland Clinic Center for Continuing Education and
Cleveland Clinic's Pathology & Laboratory Medicine Institute.